T-cell Based Immunotherapy for of Melanoma
Clinical trial NCT00937625 · COMPLETED
Trial details
- NCT number
- NCT00937625
- Sponsor
- Inge Marie Svane
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2015-01-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.